Clinical Trial Update: Safety and Efficacy of the Early Introduction of Everolimus (Certican®) With Low Dose of Cyclosporine in de Novo Kidney Recipients After 1 Month of Transplantation [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the safety and efficacy of early initiation of everolimus with low-dose cyclosporine in de novo kidney transplant recipients after 1 mon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Certican (everolimus)

Snippet

Sponsor: Yonsei University | Conditions: Planned Kidney Transplantation | Phase 4 | Status: COMPLETED